Cohen Milstein ranked as a Leading Plaintiff Class Action Antitrust Firm in the United States by the Legal 500 for the seventh year in a row
June 03, 2015
Cohen Milstein has, for the seventh year in a row, garnered a spot as a leading plaintiff class action antitrust firm, according to the Legal 500. The editors write:
With offices in Washington DC, New York, and Florida, Cohen Milstein Sellers & Toll PLLC was involved in a number of high-profile antitrust cases. For example, in In re Urethanes Antitrust Litigation the firm secured a $1bn judgment on behalf of various plaintiffs against Dow Chemical Company, which evidentially had conspired with four other companies to fix prices for certain chemicals used in the production of polyurethanes. In the In re Plasma-Derivative Protein Therapies Antitrust Litigation, the firm achieved a $128m settlement for the University of Utah Hospital in a lawsuit against biotherapy developer CSL and the Plasma Protein Therapeutics Association. The group also secured a $400m settlement with Apple, acting for the State of Texas in the In Re Electronic Books Antitrust Litigation. Kit Pierson and Richard Koffman are in charge of the practice group, in which Daniel Small is also recommended.
Partner Richard Koffman was also named, for the fourth consecutive year, in the Legal 500 United States 2015 "Leading Lawyers" list under the category of "Antitrust - Civil litigation/class actions".
The Legal 500 series has been published for over twenty years and touts itself as offering the definitive judgement of law firm capabilities.